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Abstract
Folate deficiency and hyperhomocysteinemia are found in most patients with alcoholic liver disease. Oxidative stress is one of the most important
mechanisms contributing to homocysteine (Hcy)-induced tissue injury. However it has not been examined whether exogenous administration of folic
acid attenuates oxidative stress and hepatic toxicity. The aim of this study was to investigate the in vivo effect of folic acid supplementation on
oxidative stress and hepatic toxicity induced by chronic ethanol consumption. Wistar rats (n = 32) were divided into four groups and fed 0%, 12%,
36% ethanol, or 36% ethanol plus folic acid (10 mg folic acid/L) diets. After 5 weeks, chronic consumption of the 36% ethanol diet significantly
increased plasma alanine transaminase (ALT) (P< 0.05) and aspartate transaminase (AST) (P< 0.05), triglycerides (TG) (P< 0.05), Hcy (P< 0.001),
and low density lipoprotein conjugated dienes (CD) (P < 0.05) but decreased total radical-trapping antioxidant potential (TRAP) (P < 0.001). These 
changes were prevented partially by folic acid supplementation. The 12% ethanol diet had no apparent effect on most parameters. Plasma Hcy
concentration was well correlated with plasma ALT (r = 0.612**), AST (r = 0.652*), CD (r = 0.495*), and TRAP (r = -0.486*). The results indicate
that moderately elevated Hcy is associated with increased oxidative stress and liver injury in alcohol-fed rats, and suggests that folic acid supplementation
appears to attenuate hepatic toxicity induced by chronic ethanol consumption possibly by decreasing oxidative stress.
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Introduction4)
Folate deficiency is the most common sign of malnutrition in 
patients with chronic alcoholism [1,2]. The frequent finding of 
folate deficiency in patients with chronic alcoholism suggests a 
role for folate in the pathogenesis of alcoholic liver disease 
(ALD). Folate plays an integral role in methionine metabolism. 
5-Methyltetrahydrofolate and homocysteine (Hcy) are substrates 
for methionine synthase to produce endogenous methionine 
which is a precursor of S-adeonosylmethionine (SAM). Because 
folate helps maintain normal concentrations of Hcy, methionine, 
and SAM, folate deficiency can disturb methionine metabolism, 
leading to hyperhomocysteinemia and SAM depletion. These 
metabolic changes are important features of ALD [3].
According to extensive studies in animal models, chronic 
ethanol consumption increases hepatic oxidative stress, and 
ethanol-induced liver injury is associated with free radical 
formation [4]. Folate deficiency accelerates ethanol-induced changes 
in hepatic methionine metabolism while producing enhanced 
oxidative liver injury [5]. Chronic alcoholism is associated with 
abnormal Hcy metabolism in humans and animal models.
Increasing evidence suggests that Hcy is involved in the 
pathogenesis of ALD [6]. Abnormal Hcy metabolism increases 
fat accumulation, inflammation, and injury to hepatocytes from 
rats fed alcohol [7,8]. The injury induced by Hcy involves 
oxidative damage [9-12] and the elevated Hcy plays an important 
role in various pathologies by increasing H2O2 production 
[13-15], affecting antioxidant defense systems [16], and promoting 
DNA damage [17]. Increased DNA damage triggers a form of 
programmed cell death called apoptosis. Thus, the oxidative 
insults induced by folate depletion and elevated Hcy may play 
a major role in various pathogenic states. 
Previous studies have demonstrated that peroxidative damage 
increases with ethanol intake [18,19]. The mechanisms for ALD 
include activation of CYP2E1 [20-22] and NADPH oxidase [23]. 
These mechanisms involve production of reactive oxygen species 
(ROS), and oxidative liver injury is the net result of enhanced 
generation of ROS and depletion of antioxidants such as 
glutathione [20-23]. 
Although oxidative stress is one of the important mechanisms 
contributing to Hcy-induced tissue injury, it has not been 
examined whether exogenous administration of folic acid 
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attenuates the oxidative stress and hepatic toxicity induced by 
ethanol. This study was undertaken to establish whether the 
disturbances in some antioxidant activities and hepatic methionine 
metabolism induced by chronic ethanol consumption are a 
mechanism linking chronic ethanol consumption to hepatic injury. 
We also investigated the in vivo effect of folic acid supplemen-
tation on oxidative stress and hepatic toxicity in ethanol-fed rats. 
Materials and Methods
Materials 
Lactobacillus rhamnosus (ATCC 7469) was obtained from the 
American Type Culture Collection (Manassas, VA, USA). Folic 
acid depleted casein medium was obtained from Difco Laboratories 
(Detroit, MI, USA) and 7-fluoro-benzo-2-oxa-1, 3-diazole-4- 
sulfonate (SBDF) was obtained from Wako Chemicals (Osaka, 
Japan), respectively. L-Homocystine, tri-n-butylphosphine, DL- 
methionine, met-myoglobin, 2,2’-azino-bis(3-ethylbenzothiazoline- 
6-sulfonic acid) diammonium salt (ABTS), heparin, and 
cyclohexane were purchased from Sigma (St. Louis, MO, USA). 
All chemicals were of the highest purity commercially available. 
Animal model
The Lieber-DeCarli liquid diet [24], for administering alcohol 
orally, has provided an excellent means to reproduce the early 
lesions of ALD, which include steatosis and oxidative stress. 
Thirty-two male Wistar rats (initial weight, 170-180 g) were 
obtained from Orient Bio (Seoul, Korea). After a 7 day 
acclimation, animals were randomly assigned to one of four 
groups of eight rats each: (i) Control group (C); rats were a fed 
liquid diet that was essentially the same as the diet described 
by Lieber and DeCarli [24] with the exception of a reduction 
in total lipid content from 39.6 g/L to 23 g/L and a dextrin- 
maltose supplement to account for the energy deficit. The control 
liquid diet consisted of the following components (g/L): carbohydrate, 
153 (dextran-maltose); protein, 41.4 (casein, vitamin free > 85%); 
lipids, 23 (soybean oil); cellulose, 10; minerals plus vitamins 
(AIN 76); choline bitartrate 0.53; and, xanthan gum 3. Ethanol 
was gradually introduced into the diets over 5 days. (ii) Low 
ethanol group (LE); ethanol was added to the liquid diet at 12% 
of total calories instead of dextrin-maltose. (iii) High ethanol 
group (HE); ethanol was added to the liquid diet at 36% of total 
calories. (iv) Ethanol plus folic acid group (FE); ethanol was 
added to the liquid diet at 36% of total calories with 10 mg/L 
folic acid supplementation. 
Animals in pair-fed groups (C, LE, FE) were fed the same 
amount of HE diet as that consumed by the HE group over the 
preceding 24 hrs. The amount of the diets consumed was 
monitored daily, and body weight was measured once per week. 
The diets were fed for 5 weeks. 
Rats were housed individually in plastic cages in a temperature 
(23 ± 1℃) and humidity controlled (50 ± 5%) room with a daily 
light cycle from 06:00 to 20:00 hr. Animal experiments followed 
protocols established by the NIH Guide for the Care and Use 
of Laboratory Animals, and this study was approved by the 
institutional animal care and use committee.
Sample collection 
At the end of the 5-wk feeding period, rats were fasted 
overnight and then anesthetized with carbon dioxide. Blood 
samples were collected by cardiac puncture into heparinized 
syringes. Blood was immediately centrifuged for 15 min at 1,500
× g and 4℃  to collect plasma. Liver tissues were removed, 
washed in ice-cold saline, and rapidly frozen in liquid nitrogen. 
Samples were stored at -70
oC until analysis.
Plasma alanine transaminase and aspartate transaminase
Plasma alanine transaminase (ALT) and aspartate transaminase 
(AST) activities were measured using a photometric autoanalyzer 
(ERBA Chem Pro, Transasia Bio-Medicals, Mumbai, India).
Plasma and liver triglycerides
Liver tissues were homogenized, and hepatic total lipids were 
extracted and resolved in 5% Triton-X 100 in water. Hepatic 
triglyceride (TG) content was determined by an enzymatic 
colorimetric method using commercially available kits (Sigma). 
Plasma TG content was determined by an enzymatic method 
using a photometric autoanalyzer.
Plasma homocysteine
Total plasma Hcy levels were measured by high pressure liquid 
chromatography (HPLC) with fluorometric detection (excitation 
at 385 nm and emission at 515 nm) according to Araki and Sako 
[25]. Hcy was separated with a Hypersil ODS analytical column 
(250 × 4.6 mm I.D., 5 μm particle size) (Thermo, Runcorn, UK). 
Plasma and liver folate
Folate was analysed by a microplate assay method using L. 
rhamnosus (ATCC 7469) according to Tamura [26]. Portions of 
liver were homogenized and autolysed for hydrolysis of γ
-glutamyl residues in the presence of sodium ascorbate at 37℃. 
The supernatants of liver homogenates and plasma samples were 
used for the folate assay. 
S-Adenosyl methionine and S-adenosylhomocysteine
Portions of frozen liver were homogenized with 0.4 M HClO4. 
Samples were centrifuged at 12,000 × g for 4℃ for 30 min. Each 522 Folic acid supplementation in ethanol-fed rats
Group
1) CL E H E F E
Food intake (mL/day) 83.21 ± 0.01
3)b4) 83.21 ± 0.01
b 82.43 ± 0.05
a 82.46 ± 0.06
a
Food efficiency ratio (g/mL)
2) 0.0486 ± 0.0023
a 0.0479 ± 0.0023
a 0.0587 ± 0.0018
b 0.0532 ± 0.0017
ab
Final body weight (g) 349.3 ± 6.0
a 347.6 ± 7.6
a 383.5 ± 3.7
c 365.8 ± 4.7
b
Weight gain (g/day) 4.04 ± 0.19
a 3.99 ± 0.19
a 4.84 ± 0.15
b 4.39 ± 0.14a
b
Liver weight (g/100 g body weight) 2.92 ± 0.05
a 3.03 ± 0.06
b 3.00 ± 0.03
b 3.05 ± 0.04
b
1) C ,  c o n t r o l  ( n o  e t h a n o l ) ;  L E ,  l o w  e t h a n o l  ( 1 2 %  e t h a n o l ) ;  H E , ;  h igh  ethanol  (36%  ethanol);  FE,  36%  ethanol  plus  folic  acid
2) Food  efficiency  ratio:  weight  gain  (g/day)/  food  intake  (mL/day)
3) Values  are  mean ± SE  (n = 8).
4) Values  with  different  superscript  letters  within  a  row  are  significantly  different  at  P < 0.05  by  Duncan’s  multiple-range  test. 
Table 1. Effects of folic acid supplementation on food intake, body weight, and liver weight in ethanol-fed rats
Group
1) CL E H E F E
Plasma folate (nmol/L) 42.53 ± 3.14
2)ab3) 47.07 ± 3.24
ab 37.33 ± 3.33
a 50.60 ± 4.26
b
Liver folate (μmol/g) 4.23 ± 0.22
ab 4.19 ± 0.24
ab 4.13 ± 0.19
a 4.91 ± 0.44
b
Plasma Hcy (nmol/mL) 8.29 ± 0.25
a 8.87 ± 0.23
a 12.07 ± 0.84
c 10.32 ± 0.36
b
Plasma Cys (nmol/mL)  268.5 ± 10.1
a 274.5 ± 11.9
a 329.4 ± 23.3
b 302.0 ± 13.8a
b
Liver SAM (nmol/g) 8.57 ± 0.83
NS4) 7.32 ± 0.84 6.89 ± 1.08 6.92 ± 1.29
Liver SAH (nmol/g) 6.60 ± 0.28
NS 5.75 ± 0.54 5.58 ± 0.69 5.48 ± 0.34
Liver SAM/SAH ratio 1.30 ± 0.13
NS 1.33 ± 0.16 1.25 ± 0.14 1.28 ± 0.21
1) C,  control  (no  ethanol);  LE,  12%  ethanol;  HE,  36%  ethanol;  FE,  36%  ethanol  plus  folic  acid
2) Values  are  mean ± SE  (n = 8).
3) Values  with  different  superscript  letters  within  a  row  are  significantly  different  at  P < 0.05  by  Duncan’s  multiple-range  test. 
4) NS,  not  significant
Table 2. Effects of folic acid supplementation on plasma and liver folate and on plasma and liver methionine metabolites
supernatant was filtered through a 0.45-μm filter. SAM and SAH 
were measured on a Shimadzu LC-10 HPLC system equipped 
with 250 × 4.6 mm Ultrasphere 5-μm ODS Betasil analytical 
column (Thermo) according to Wagner et al. [27].
Plasma total radical-trapping antioxidant potential
Total radical-trapping antioxidant potential (TRAP) was 
analyzed using an inhibition assay according to Rice-Evans and 
Miller [28]. Plasma samples were incubated with a peroxidase 
(met-myoglobin) and H2O2 to produce the cation ABTS
+. A 
relatively stable blue-green color occurred and was measured at 
30℃ at 740 nm. Antioxidants in the added plasma sample cause 
suppression of this color production to a degree that is proportional 
to their concentration. The standard procedure consisted of 
determination of the Trolox equivalent antioxidant capacity 
(mmol/L). 
Conjugated diene formation of LDL
Oxidation of LDL was identified by measuring the formation 
of conjugated dienes (CD), which is an early lipid peroxidation 
event. LDL was isolated with buffered heparin as described 
previously [29,30]. To estimate LDL oxidation, lipids were 
extracted from LDL samples by chloroform-methanol (2:1) and 
dried under nitrogen, then redissolved in cyclohexane. The 
quantity of CDs in LDL was assessed by monitoring the change 
in absorbance at A234 at the indicated time points [31]. The results 
are expressed as μmol/L.
Statistical analysis
Results are expressed as mean ± standard error (SE). Data were 
analyzed by one-way analysis of variance (ANOVA) followed 
by Duncan’s multiple range test. Data were considered significantly 
different at P < 0.05. Pearson’s correlation procedure was used 
for the correlation analysis. All statistical analyses were performed 
using SPSS 18.0 for Window (SPSS, Inc., Chicago, IL, USA).
Results
We evaluated the effects of folic acid supplementation to 
correct the ethanol-induced perturbation in liver methionine 
metabolism, oxidative stress parameters, and experimental liver 
injury. As shown in Table 1, the 36% ethanol diet increased 
both final body weight (P < 0.001) and weight gain (P < 0.001) 
compared with those in rats fed the control diet. Folic acid 
supplementation of the ethanol diet resulted in a significant 
decrease in body weight compared with rats fed the HE diet. 
However, the LE diet had no apparent effect on body weight. 
When liver weight was expressed as a percent of body weight, 
a significant increase was found in all ethanol-fed rats (LE, HE, 
and FE) compared with rats fed the control diet (P < 0.05).
As shown in Table 2, liver folate concentrations remained 
unchanged in rats fed the LE or HE diets, and increased slightly 
in rats fed the FE diet compared with those in the control group. 
However, the HE diet tended to decrease plasma folate 
concentration slightly as compared to rats fed the control or LE 
diets. Plasma folate increased significantly in rats fed the FE Soo-Jung Lee et al. 523
Group
1) CL E H E F E
ALT (units/L) 160.3 ± 11.1
2)a3) 184.0 ± 5.2
b 208.5 ± 8.2
c 180.7 ± 6.2
b
AST (units/L) 187.1 ± 9.11
a 197.1 ± 2.02
a 275.5 ± 7.14
c 245.6 ± 12.0
b
Plasma TG 
(mg/dL)
67.01 ± 1.65
a 66.69 ± 0.89
3)a 77.18 ± 3.34
b 67.29 ± 0.96
a
Liver TG 
(nmole/g)
2.82 ± 0.13
NS4) 4.21 ± 0.31 3.18 ± 0.37 2.84 ± 1.19 
1) C, control (no ethanol); LE, 12% ethanol; HE, 36% ethanol; FE, 36% ethanol plus 
folic  acid
2) Values  are  mean ± SE  (n = 8).
3) Values with different superscript letters within a row are significantly different at 
P < 0.05  by  Duncan’s  multiple-range  test. 
4) NS,  not  significant
Table 3. Effects of folic acid supplementation on plasma aminiotransferases and
plasma and liver triglycerides in ethanol-fed rats
Group
1) CL E H E F E
TEAC
2) 
(mmol/L)
1.4375 ± 0.000
3)d4) 1.4284 ± 0.0017
c 1.4129 ± 0.0022
a 1.4213 ± 0.0002
b
CD
5) 
(μmol/L)
30.64 ± 1.38
ab 31.23 ± 0.86
ab 34.97 ± 1.28
b 29.68 ± 1.04
a
1) C, control (no ethanol); LE, 12% ethanol; HE, 36% ethanol; FE, 36% ethanol plus 
folic  acid
2) The results of plasma TRAP measurements are expressed as Trolox equivalent 
antioxidant  capacity  (TEAC),  mmol/L. 
3) Values  are  mean ± SE  (n = 8). 
4) Values with different superscript letters within a row are significantly different at 
P < 0.05.  by  Duncan’s  multiple-range  test 
5) Conjugated  dienes  of  plasma  LDL
Table 4. Effects of folic acid supplementation on plasma total radical-trapping
antioxidant potential (TRAP) and conjugated dienes in ethanol-fed rats
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Fig 1. Pearson’s correlation coefficients between plasma homocysteine (Hcy) concentration and plasma aspartate aminotransferase (AST), alanine aminotransferase 
(ALT), low density lipoprotein (LDL) conjugated dienes, and total radical-trapping antioxidant potential (TRAP) in rats chronically fed ethanol. 
diet compared with rats fed the HE diet (P< 0.01). Both plasma 
Hcy (P < 0.001) and cysteine (P < 0.05) increased significantly 
in rats fed the HE diet compared to rats fed the control diet 
(12.07 nmol/mL vs. 8.29 nmol/mL, 329.4 nmol/mL vs. 268.5 
nmol/mL, respectively) (Table 2). Folic acid supplementation 
decreased plasma Hcy slightly in ethanol-fed rats. However, liver 
SAM, SAH, and the SAM/SAH ratio remained unchanged by 
feeding either the HE diet or by folic acid supplementation.
Plasma AST and AST activity was measured to assess whether 
folic acid supplementation influenced the development of 
ethanol-induced liver injury (Table 3). The HE diet significantly 
elevated plasma ALT (P < 0.05) and AST (P < 0.05) activities 
indicating hepatic toxicity. Supplementation of ethanol-fed rats 
(FE) with folic acid reduced ALT and AST activity significantly 
compared to that in rats fed the HE ethanol diets, which 
demonstrated that ethanol-induced liver injury can be alleviated 
by folic acid supplementation.
The high ethanol diet caused significant increase in plasma 
TG levels compared to that in controls, but the LE diet had no 
apparent effect on plasma TG (Table 3). Supplementation of 
ethanol-fed rats with folic acid resulted in decreased plasma TG 
to control levels (P < 0.05). However, liver TG remained 
unchanged either by ethanol administration or by folic acid plus 
ethanol administration. 524 Folic acid supplementation in ethanol-fed rats
TRAP, which represents non-enzymatic plasma antioxidant 
activity, decreased significantly in plasma of rats fed the LE or 
HE diets (P < 0.01) (Table 4). Folic acid supplementation 
elevated plasma TRAP in the ethanol-fed animal models. Levels 
of CDs in isolated LDL were analyzed as an oxidative stress 
parameter in plasma (Table 4). CD levels in rats administered 
the HE diet tended to be significantly higher than those of the 
control group, and the FE diet decreased CD to the lowest levels 
in this study (P < 0.05). CD levels remained unchanged in the 
plasma of the LE group compared to that in the control group.
We performed a correlation analysis between plasma Hcy and 
plasma aminotransferase activities and oxidative parameters to 
investigate whether Hcy levels were associated with the 
parameters related to ethanol-induced hepatic toxicity and 
oxidative stress (Fig. 1). We found a significant correlation 
between Hcy and AST (r = 0.652, P < 0.01), Hcy and ALT (r
= 0.612, P< 0.05), Hcy and CD levels (r = 0.495, P< 0.05), and 
Hcy and TRAP levels (r = -0.486, P < 0.05). These results 
indicate that Hcy may cause hepatic toxicity by elevating 
oxidative stress in rats fed a chronic ethanol diet.
Discussion
Numerous reports have demonstrated that oxidative stress plays 
an important role in the development of alcoholic liver disease 
[32-34]. Both alcoholic patients and rats fed ethanol have 
elevated Hcy and decreased folate levels [35-37]. Although folate 
deficiency and hyperhomocysteinemia seem to be involved in 
the pathogenesis of alcoholic liver disease, practically nothing 
has been reported on the effects of exogenous administration of 
folic acid on oxidative stress and hepatic toxicity in ethanol-fed 
rats. The present study is the first to provide data on the ability 
of folic acid supplementation to correct ethanol-induced 
perturbations in methionine metabolism and experimental liver 
injury in ethanol-fed rats, an animal model of alcoholic liver 
disease. 
Previous studies have shown that ethanol-induced Hcy elevation 
triggers the endoplasmic reticulum (ER) stress response that 
mediates oxidative and inflammatory processes in the development 
of both vascular injury and hepatic steatonecrosis [6,38]. Ethanol 
and its metabolites, such as acetaldehyde and fatty acids, could 
generate a large amount of ROS during metabolism by the 
microsomal enzyme CYP2E1. ROS can damage liver cells 
directly or by enhancing the sensitivity of hepatocytes to lipid 
peroxidation [39,40]. Pathogenesis of alcohol-induced hepatic 
steatosis and steatohepatitis is thought to be dependent on 
oxidative stress, whereby lipid peroxidation products facilitate 
the inflammatory response. Oral folic acid supplementation 
improves cardiovascular functions in patients with mild homocy-
steinemia [41]. 
We observed that chronic ethanol feeding (HE) significantly 
elevated plasma Hcy, AST, ALT, and TG. In contrast, folic acid 
supplementation partially reduced plasma Hcy, ALT, AST, and 
TG in ethanol-fed rats. These results suggest that folic acid 
supplementation offers a hepatoprotective effect in ethanol- 
induced liver injury by decreasing Hcy. It has become apparent 
that abnormal hepatic methionine metabolism is integral to 
hepatic toxicity, and that hyperhomocysteinemia resulting from 
a disturbance in methionine metabolism plays an important role 
in alcohol-induced liver injury [42]. Because ethanol-induced 
hyperhomocysteinemia is toxic to liver cells, we also examined 
the correlation between plasma Hcy and aminotransferase levels 
(Fig. 1). We found that plasma Hcy concentration was positively 
correlated with plasma ALT and AST levels in rats fed the 
ethanol diets. 
Total antioxidant defense, represented by the TRAP measure-
ment, decreased significantly in plasma of rats fed the HE diet 
but was partially restored by folic acid supplementation (P <
0.001). Elevated TRAP following folic acid supplementation may 
imply improved antioxidant capacity to prevent damage 
associated with free radicals. Hyperhomocysteinemia is associated 
with ER stress, leading to the activation of ER-dependent 
apoptosis and upregulation of lipid synthesis in hepatocytes [6]. 
We also observed strong correlations between plasma Hcy and 
oxidative stress markers in ethanol-fed rats (Fig. 1). CD levels in 
the isolated LDL samples from the HE group were significantly 
higher than those in the control group (P < 0.05) (Table 3), 
suggesting that a high concentration ethanol diet induced 
production of oxygen free radicals leading to lipid peroxidation. 
We observed that a decreased CD level following folic acid 
supplementation in ethanol-fed rats. These results suggest that 
decreasing Hcy to a certain level by folic acid supplementation 
might partially prevent oxidative stress. 
In this study, oxidative status markers were modified by folic 
acid supplementation in the sense of lower oxidative stress. 
However, recent studies have suggested that folate may have 
protective effects independent of Hcy-lowering effects through 
free-radical scavenging activity [43,44]. The protective effects 
of folic acid supplementation on endothelial dysfunction may be 
due to a direct effect of folate on free-radical oxidation of LDL 
lipids. The plausible rationale is free radical scavenging activity 
of folate [44]. Because liver injury by free radicals is a potential 
participating mechanism in alcoholic liver disease, and oral folic 
acid supplementation may be a safe and inexpensive way to 
reducing oxidative damage, further studies are needed to elucidate 
the possible mechanism underlying these protective effects.
In summary, the results show that folic acid supplementation 
has potential implications for alleviating hepatic toxicity by 
preventing homocysteinemia in ethanol-fed rats. Considering the 
oxidative stress elicited by Hcy, folic acid supplementation could 
contribute to correct the observed decrease in antioxidant 
potential and the increase in oxidative stress induced by chronic 
ethanol treatment.Soo-Jung Lee et al. 525
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